Builders FirstSource
BLDR
$85.30
+0.11%
Builders FirstSource, Inc. is a leading manufacturer and supplier of building materials and services, operating within the construction industry. The company's core offerings include structural building products like factory-built roof and floor trusses, wall panels, vinyl windows, custom millwork, and engineered wood, complemented by professional installation and turn-key framing services. It has established itself as a dominant, integrated supplier in the residential construction sector, serving a broad customer base from large production builders to small custom homebuilders. The current investor narrative is heavily focused on the company's cyclical exposure to the housing market, with recent financial results showing a significant year-over-year revenue decline, prompting debate over the timing of a potential recovery in housing starts and the company's ability to manage costs and margins through the downturn.…
BLDR
Builders FirstSource
$85.30
Investment Opinion: Should I buy BLDR Today?
Rating: Hold. The core thesis is that BLDR is a deeply cyclical stock priced for a downturn, but the timing of a recovery is too uncertain to warrant a Buy rating, given the severe fundamental deterioration and lack of positive price momentum.
Supporting evidence for this Hold stance includes the stock's undemanding forward P/E of 11.13x, which prices in a significant earnings recovery to $9.58 per share. The low Price-to-Sales ratio of 0.75x offers a margin of safety. Furthermore, robust trailing FCF of $853.3M and a solid current ratio of 1.86 provide financial resilience. However, these positives are counterbalanced by concrete negatives: a -12.1% YoY revenue decline, an operating margin that collapsed to 1.84%, and severe technical underperformance (-58.40% relative strength vs. S&P 500).
The two biggest risks are a deeper-than-expected housing slump invalidating the EPS recovery forecast, and further margin compression eroding the remaining profitability. This Hold would upgrade to a Buy if the stock stabilizes above its 52-week low on improving housing start data and shows sequential margin improvement in upcoming quarters. It would downgrade to a Sell if revenue decline accelerates beyond -15% YoY or if the forward P/E multiple expands above 15x without corresponding earnings growth. Based on current data, the stock appears fairly valued relative to the high-risk, recovery-dependent narrative it embodies.
Sign up to view all
BLDR 12-Month Price Forecast
BLDR is a binary bet on the housing cycle where the current price balances deep-value multiples against worsening fundamentals. The neutral stance reflects the high probability (50%) of a muddle-through base case where the stock treads water. The substantial gap between the trailing P/E (26.34x) and forward P/E (11.13x) is the crux of the investment: it offers upside if forecasts are met but poses high risk if they are not. Confidence is medium due to the conflicting signals from strong cash flow and weak margins. The stance would upgrade to bullish on evidence of sequential revenue stabilization and margin improvement in the next two quarters. It would turn bearish if the stock breaks below $76.50 with high volume, signaling the expected recovery is failing to materialize.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Builders FirstSource's 12-month outlook, with a consensus price target around $110.89 and implied upside of +30.0% versus the current price.
Average Target
$110.89
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$68 - $111
Analyst target range
Analyst coverage for BLDR is limited, with only 5 analysts providing estimates, indicating it may have less institutional following than larger caps. The available data shows consensus estimates for the coming year, including an average EPS forecast of $9.58 (range: $9.16 to $9.88) and average revenue of $17.76 billion. Specific consensus price targets and Buy/Hold/Sell ratings are not provided in the dataset, preventing a calculation of implied upside or downside to a consensus target. The institutional ratings data shows recent analyst actions are mixed but leaning cautious. Since January 2026, there have been 10 ratings actions, with a preponderance of 'Hold', 'Neutral', or 'Equal-Weight' stances from firms like Stephens & Co., Stifel, Wells Fargo, DA Davidson, and Baird. However, there have been bullish calls as well, with RBC Capital upgrading to 'Outperform' and Barclays and Benchmark maintaining 'Overweight' and 'Buy' ratings, respectively. This split indicates high uncertainty and debate around the near-term outlook for housing and the stock. The wide dispersion in potential outcomes, reflected in the lack of a unified price target, signals low conviction and high fundamental uncertainty among the analyst community.
Bulls vs Bears: BLDR Investment Factors
The investment debate for BLDR is a classic battle between cyclical valuation and deteriorating fundamentals. The bear case currently holds stronger evidence, as concrete financial deterioration (Q4 revenue -12.1%, operating margin collapse to 1.84%) and severe technical damage (-31.57% in 3 months) outweigh the potential embedded in forward-looking valuation metrics. The single most important tension is the timing and magnitude of the housing market recovery. If the analyst forecast for a sharp EPS rebound to $9.58 proves accurate, the current forward P/E of 11.13x is compelling. However, if the downturn deepens or persists longer than expected, the high operational and financial leverage could lead to further significant earnings misses and price declines toward the 52-week low.
Bullish
- Strong Free Cash Flow Generation: Despite the cyclical downturn, BLDR generated $853.3 million in trailing twelve-month free cash flow. This robust cash generation provides the company with significant financial flexibility to service its debt, repurchase shares, and weather the housing market slowdown without liquidity stress.
- Undemanding Forward Valuation: The stock trades at a forward P/E of 11.13x, based on analyst consensus EPS of $9.58. This multiple is not demanding and suggests the market has already priced in a significant earnings decline, leaving room for multiple expansion if earnings stabilize or recover as forecasted.
- Analyst EPS Forecast Implies Strong Recovery: Analysts project a sharp earnings rebound to an average of $9.58 per share for the coming year. This forecast, if achieved, would represent a massive recovery from the depressed Q4 2025 EPS of $0.28, indicating confidence in a cyclical upswing and operational leverage.
- Low Absolute Price-to-Sales Multiple: With a Price-to-Sales ratio of 0.75x and an EV-to-Sales of 0.94x, BLDR trades at low absolute multiples typical for a cyclical stock in a downturn. This valuation provides a margin of safety and limits downside if the housing market remains weak for an extended period.
Bearish
- Severe Revenue and Margin Contraction: Q4 2025 revenue declined -12.1% YoY, with net income plummeting from $190.2M to $31.5M. The operating margin collapsed to 1.84% from 7.96% a year ago, demonstrating severe negative operating leverage as fixed costs weigh on falling sales.
- Pronounced Technical Downtrend: The stock is down -31.57% over 3 months and -28.88% over 1 year, underperforming the S&P 500 by -58.40% for the year. Trading just 11.5% above its 52-week low of $76.50, the chart shows persistent selling pressure and a lack of near-term catalysts.
- High Financial and Operational Leverage: A debt-to-equity ratio of 1.30 increases financial risk in a downturn. Combined with a beta of 1.636, the stock is 64% more volatile than the market, amplifying downside moves during sector weakness and increasing the risk of further price declines.
- Analyst Sentiment Reflects High Uncertainty: Recent analyst actions show a preponderance of 'Hold' or 'Neutral' ratings, with only 5 analysts providing estimates. This limited coverage and mixed sentiment indicate low conviction and high fundamental uncertainty regarding the timing and strength of a housing recovery.
BLDR Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -28.88% and a 3-month decline of -31.57%, significantly underperforming the broader market. Currently trading at $85.30, the price sits just 11.5% above its 52-week low of $76.50 and 43.5% below its 52-week high of $151.03, positioning it in the lower quartile of its annual range and suggesting it is being priced as a deep value or distressed opportunity, though risks of further decline remain. Recent momentum shows continued weakness, with the stock down -6.38% over the past month, which contrasts with a slight positive move in the S&P 500 (+0.46%), indicating persistent negative sentiment and a lack of near-term catalysts to arrest the slide. The stock's beta of 1.636 confirms it is approximately 64% more volatile than the market, a critical factor for risk management given its current trajectory. Key technical support is clearly defined at the 52-week low of $76.50, while resistance is far overhead at the 52-week high of $151.03. A decisive breakdown below $76.50 would signal a new leg down and likely trigger further selling, whereas a sustained move above this recent low could indicate a tentative base is forming. The stock's high beta of 1.636, combined with a maximum drawdown of -47.16% over the observed period, underscores its high-risk profile; investors must be prepared for amplified swings relative to the market, especially during periods of economic uncertainty impacting the housing sector. Volume and relative strength data further confirm the bearish bias. The stock's 1-month relative strength of -6.84% and 1-year relative strength of -58.40% versus the S&P 500 highlight severe and sustained underperformance. The price action from a peak near $128 in mid-January 2026 to the current level near $85 illustrates a clear breakdown, with the stock failing to hold any intermediate support levels, reflecting ongoing distribution and a lack of buyer conviction.
Beta
1.64
1.64x market volatility
Max Drawdown
-47.2%
Largest decline past year
52-Week Range
$77-$151
Price range past year
Annual Return
-28.9%
Cumulative gain past year
| Period | BLDR Return | S&P 500 |
|---|---|---|
| 1m | -6.4% | +2.6% |
| 3m | -31.6% | -2.3% |
| 6m | -30.4% | +2.6% |
| 1y | -28.9% | +27.3% |
| ytd | -18.5% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BLDR Fundamental Analysis
Revenue is in a clear deceleration phase, with Q4 2025 sales of $3.36 billion representing a -12.1% year-over-year decline. This follows a sequential downtrend from stronger quarters earlier in the year (Q2 2025: $4.23B, Q3 2025: $3.94B), indicating the cyclical housing slowdown is materially impacting top-line performance. Segment data shows revenue is broadly distributed across Lumber ($773M), Manufactured Products ($743M), Specialty Building Products ($949M), and Windows/Doors ($894M), suggesting the weakness is industry-wide rather than isolated to one product line. This trajectory implies the investment case is currently a bet on a housing market recovery, not on organic growth. Profitability has deteriorated sharply alongside revenue. While the company remains profitable on a net income basis, Q4 2025 net income plunged to $31.5 million from $190.2 million in the year-ago quarter, and the net margin compressed to 0.94% from 4.98%. Gross margin for the quarter was 29.84%, down from 32.30% a year ago, indicating pricing pressure and/or a less favorable sales mix. The operating margin fell to 1.84% from 7.96%, showcasing significant operating leverage to the downside as fixed costs are spread over lower revenue. This margin compression is a key risk if the downturn persists. The balance sheet and cash flow present a mixed but manageable picture. The company maintains a solid current ratio of 1.86 and generated substantial trailing twelve-month free cash flow of $853.3 million. However, the debt-to-equity ratio of 1.30 indicates a leveraged capital structure, which increases financial risk in a downturn. Return on Equity (ROE) of 10.0% and Return on Assets (ROA) of 4.5%, while positive, have declined from prior peaks. The strong free cash flow provides flexibility to service debt and potentially repurchase shares, as evidenced by stock repurchase activity in recent cash flow statements, offering a partial offset to the weak earnings picture.
Quarterly Revenue
$3.4B
2025-12
Revenue YoY Growth
-0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$853284000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BLDR Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 26.34x, while the forward PE is significantly lower at 11.13x. This substantial gap implies the market expects a strong earnings recovery in the coming year, as analysts forecast EPS to rebound to an average of $9.58 from a depressed trailing base. Compared to industry averages, the stock's valuation presents a complex picture. Its Price-to-Sales (PS) ratio of 0.75x and EV-to-Sales of 0.94x are low absolute multiples, typical for a cyclical business in a downturn. The forward PE of 11.13x is also not demanding if the earnings recovery materializes. The key question is whether these multiples adequately discount the ongoing cyclical risks and margin pressure, or if they already price in a pessimistic scenario, leaving room for multiple expansion on any positive housing data. Historically, the current valuation sits well below its own historical peaks. The trailing PE of 26.34x is far below the 90.31x recorded at the end of Q4 2025 (driven by depressed earnings) and also below levels seen during the 2021-2022 boom (e.g., low single-digits). The PS ratio of 0.75x is near the low end of its historical range observed in the provided data (which shows PS ratios frequently above 3x in recent years). This suggests the stock is priced for a significant downturn, and any stabilization or improvement in fundamentals could lead to a sharp re-rating higher, though it remains vulnerable if the downturn deepens.
PE
26.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~90x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are elevated. BLDR's profitability is highly sensitive to the housing cycle, as evidenced by the Q4 2025 net margin compression to 0.94% from 4.98% a year ago. The company carries significant leverage with a debt-to-equity ratio of 1.30, which could pressure financial flexibility if the downturn extends. While strong trailing FCF of $853.3M provides a buffer, the risk lies in sustained margin pressure from pricing competition and unfavorable sales mix, which drove the gross margin down to 29.84% in Q4 from 32.30%.
Market & Competitive Risks stem from its pure-play cyclical exposure. The stock's beta of 1.636 confirms it is approximately 64% more volatile than the market, making it highly susceptible to macro shifts in interest rates and housing sentiment. Trading at a forward P/E of 11.13x, the valuation is not demanding, but it remains vulnerable to multiple compression if the expected earnings recovery is delayed. The lack of a unified, bullish analyst consensus and limited coverage (only 5 analysts) suggests low institutional conviction, increasing the stock's sensitivity to negative news flow.
Worst-Case Scenario involves a prolonged housing recession coupled with sustained high interest rates. This could trigger a chain where revenue declines accelerate beyond the current -12.1% YoY rate, leading to further operating margin erosion below 1.84%. Combined with its high financial leverage, this could strain cash flow, potentially forcing asset sales or dilutive capital raises. In this adverse scenario, the stock could realistically re-test and break below its 52-week low of $76.50, implying a downside of approximately -10% from the current $85.30. A more severe drawdown, aligning with the stock's maximum observed drawdown of -47.16%, could see prices fall toward the $70 range, representing a loss of -18% or more.
FAQ
The key risks are, in order of severity: 1) Cyclical Demand Risk: Continued decline in housing starts could lead to further revenue drops beyond the current -12.1% YoY and more margin compression from the already low 1.84% operating margin. 2) Financial Leverage Risk: A debt-to-equity ratio of 1.30 amplifies financial stress if the downturn is prolonged. 3) Execution & Forecast Risk: The entire bullish thesis relies on EPS rebounding to $9.58; any delay or shortfall would cause a severe de-rating. 4) Market Risk: The stock's high beta of 1.636 means it will fall significantly more than the market during any broad sell-off or sector rotation.
The 12-month forecast for BLDR is highly uncertain, centered on three scenarios. The Base Case (50% probability) sees the stock trading between $90 and $105, assuming a sluggish housing market and BLDR meeting most of its $9.58 EPS forecast. The Bull Case (30% probability) projects a range of $120 to $135 on a swift housing recovery and earnings beat. The Bear Case (20% probability) warns of a drop to $70-$80 if the downturn deepens and EPS forecasts are cut. The most likely outcome is the Base Case, hinging on the critical assumption that the housing market does not deteriorate further from current levels.
BLDR's valuation sends mixed signals, making it fairly valued relative to its high-risk profile. On an absolute basis, a Price-to-Sales ratio of 0.75x and a forward P/E of 11.13x appear cheap and potentially undervalued if a strong earnings recovery occurs. However, the trailing P/E of 26.34x is elevated due to depressed earnings, and the stock trades just 11.5% above its 52-week low, suggesting the market is pricing in significant distress. Compared to its own historical multiples (PS has been above 3x), it seems undervalued. The valuation implies the market expects a sharp earnings rebound; therefore, it is fairly valued only if that rebound materializes as forecasted.
BLDR is a high-risk, high-potential-reward stock that may be a good buy only for specific investors. For contrarian investors with a high risk tolerance and a long-term horizon (2+ years), the current valuation (forward P/E of 11.13x, PS of 0.75x) offers an attractive entry point to bet on a housing recovery. The implied upside is significant if analyst EPS forecasts of $9.58 are met. However, it is not a good buy for most investors, given the severe fundamental deterioration (Q4 revenue -12.1%, margin collapse), lack of positive price momentum, and high volatility (beta 1.636). The biggest downside risk is a prolonged housing slump leading to further earnings misses.
BLDR is strictly suitable for long-term investors with a minimum horizon of 2-3 years. The stock is in a pronounced downtrend with high volatility (beta 1.636), making it a poor candidate for short-term trading as it lacks positive momentum and clear catalysts. Its investment case is a bet on the multi-year housing cycle turning upward, which requires patience. The company does not pay a dividend, eliminating an income component. Therefore, only investors who can tolerate significant interim volatility and are willing to wait for a cyclical recovery should consider BLDR for a long-term, contrarian portfolio allocation.
